| Followers | 843 |
| Posts | 122988 |
| Boards Moderated | 9 |
| Alias Born | 09/05/2002 |
Sunday, August 05, 2007 3:07:17 PM
Re: Quiz
>They have an agreement with Teva to develop 2 biogeneric drugs that have annual sales of $xB and will go off patent in about 3 years (that's a nice quiz).<
My guesses are: Cerezyme and Enbrel.
>They have an agreement with Teva to develop 2 biogeneric drugs that have annual sales of $xB and will go off patent in about 3 years (that's a nice quiz).<
My guesses are: Cerezyme and Enbrel.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent PLX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 11:06:20 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 10:57:15 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/30/2026 08:35:11 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/30/2026 08:30:39 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 03/30/2026 09:31:32 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/18/2026 11:12:44 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/18/2026 10:56:54 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 11:51:13 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 10:10:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2026 03:09:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2026 11:56:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/23/2025 12:25:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 09:34:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 11:58:56 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 11:54:59 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2025 09:44:01 PM
- Protalix BioTherapeutics Inc stock plunges after CHMP rejects alternative Elfabrio dosing regimen • IH Market News • 10/17/2025 02:50:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2025 12:08:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2025 09:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2025 09:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2025 09:00:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2025 09:00:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2025 09:00:14 PM
